Last update: June 4, 2016

Myoinositol

Very Low Risk for breastfeeding


Safe. Compatible.
Not risky for breastfeeding or infant.

Product of natural origin and glucose isomer which is present in cereals, fruits, nuts and vegetables, as well as animal offal and milk. It is metabolized to glucose.
Considered as part of vitamin B (Bh) with no clear evidence of its activity as such or signs of deficiency.

It is found in breast milk. A higher concentration in the plasma of newborns than that in their mothers has been found. Breastfed infants show higher plasma levels of Inositol than formula-fed ones or after parenteral nutrition.
It has been used in the newborn period to treat lung disorders and retinopathy associated to prematurity.

No clear therapeutic indications nor cases of overdose poisoning with this product are known.

Alternatives

We do not have alternatives for Myoinositol since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Myoinositol is also known as Inositol. Here it is a list of alternative known names::


Myoinositol in other languages or writings:

Group

Myoinositol belongs to this group or family:

Tradenames

Main tradenames from several countries containing Myoinositol in its composition:

  • Dertrase™. Contains other elements than Myoinositol in its composition
  • Inositech

Pharmacokinetics

Variable Value Unit
Molecular weight 180 daltons

References

  1. Fang JL, Sorita A, Carey WA, Colby CE, Murad MH, Alahdab F. Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis. Pediatrics. 2016 Abstract
  2. AESAN. Informe del Comité Científico de la Agencia Española de Seguridad Alimentaria y Nutrición (AESAN) sobre condiciones de uso de determinadas sustancias distintas de vitaminas, minerales y plantas para ser empleadas en complementos alimenticios - 1. Revista del comité científico nº 17. 2012 Full text (in our servers)
  3. Brown LD, Cheung A, Harwood JE, Battaglia FC. Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes. J Nutr. 2009 Abstract
  4. Huisman M, van Beusekom CM, Lanting CI, Nijeboer HJ, Muskiet FA, Boersma ER. Triglycerides, fatty acids, sterols, mono- and disaccharides and sugar alcohols in human milk and current types of infant formula milk. Eur J Clin Nutr. 1996 Abstract
  5. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med. 1992 Abstract
  6. Pereira GR, Baker L, Egler J, Corcoran L, Chiavacci R. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. Am J Clin Nutr. 1990 Abstract Full text (link to original source)
  7. Jenness R. The composition of human milk. Semin Perinatol. 1979 Abstract

Total visits

3,033

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM